Skip to content

SION SION Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
AbbVie logo
AbbVieABBV
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's common stock, shares authorized (in shares)?
SION (SION) reported common stock, shares authorized (in shares) of $500M in Q1 2026.
How has SION's common stock, shares authorized (in shares) changed year-over-year?
SION's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $500M to $500M.